The Pain in Neuropathy Study (PiNS)

Disabling neuropathic pain (NeuP) is a common sequel of diabetic peripheral neuropathy (DPN). We aimed to characterise the sensory phenotype of patients with and without NeuP, assess screening tools for NeuP, and relate DPN severity to NeuP. The Pain in Neuropathy Study (PiNS) is an observational cr...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: Themistocleous, A, Ramirez, J, Shillo, P, Lees, J, Selvarajah, D, Orengo, C, Tesfaye, S, Rice, A, Bennett, D
Format: Journal article
Sprache:English
Veröffentlicht: Wolters Kluwer Health, Inc 2016
_version_ 1826263120723574784
author Themistocleous, A
Ramirez, J
Shillo, P
Lees, J
Selvarajah, D
Orengo, C
Tesfaye, S
Rice, A
Bennett, D
author_facet Themistocleous, A
Ramirez, J
Shillo, P
Lees, J
Selvarajah, D
Orengo, C
Tesfaye, S
Rice, A
Bennett, D
author_sort Themistocleous, A
collection OXFORD
description Disabling neuropathic pain (NeuP) is a common sequel of diabetic peripheral neuropathy (DPN). We aimed to characterise the sensory phenotype of patients with and without NeuP, assess screening tools for NeuP, and relate DPN severity to NeuP. The Pain in Neuropathy Study (PiNS) is an observational cross-sectional multicentre study. A total of 191 patients with DPN underwent neurological examination, quantitative sensory testing, nerve conduction studies, and skin biopsy for intraepidermal nerve fibre density assessment. A set of questionnaires assessed the presence of pain, pain intensity, pain distribution, and the psychological and functional impact of pain. Patients were divided according to the presence of DPN, and thereafter according to the presence and severity of NeuP. The DN4 questionnaire demonstrated excellent sensitivity (88%) and specificity (93%) in screening for NeuP. There was a positive correlation between greater neuropathy severity (r = 0.39, P < 0.01), higher HbA1c (r = 0.21, P < 0.01), and the presence (and severity) of NeuP. Diabetic peripheral neuropathy sensory phenotype is characterised by hyposensitivity to applied stimuli that was more marked in the moderate/severe NeuP group than in the mild NeuP or no NeuP groups. Brush-evoked allodynia was present in only those with NeuP (15%); the paradoxical heat sensation did not discriminate between those with (40%) and without (41.3%) NeuP. The “irritable nociceptor” subgroup could only be applied to a minority of patients (6.3%) with NeuP. This study provides a firm basis to rationalise further phenotyping of painful DPN, for instance, stratification of patients with DPN for analgesic drug trials.
first_indexed 2024-03-06T19:46:40Z
format Journal article
id oxford-uuid:22859d9d-f5de-4ca3-9ec1-b8fca5fac505
institution University of Oxford
language English
last_indexed 2024-03-06T19:46:40Z
publishDate 2016
publisher Wolters Kluwer Health, Inc
record_format dspace
spelling oxford-uuid:22859d9d-f5de-4ca3-9ec1-b8fca5fac5052022-03-26T11:39:17ZThe Pain in Neuropathy Study (PiNS)Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:22859d9d-f5de-4ca3-9ec1-b8fca5fac505EnglishSymplectic Elements at OxfordWolters Kluwer Health, Inc2016Themistocleous, ARamirez, JShillo, PLees, JSelvarajah, DOrengo, CTesfaye, SRice, ABennett, DDisabling neuropathic pain (NeuP) is a common sequel of diabetic peripheral neuropathy (DPN). We aimed to characterise the sensory phenotype of patients with and without NeuP, assess screening tools for NeuP, and relate DPN severity to NeuP. The Pain in Neuropathy Study (PiNS) is an observational cross-sectional multicentre study. A total of 191 patients with DPN underwent neurological examination, quantitative sensory testing, nerve conduction studies, and skin biopsy for intraepidermal nerve fibre density assessment. A set of questionnaires assessed the presence of pain, pain intensity, pain distribution, and the psychological and functional impact of pain. Patients were divided according to the presence of DPN, and thereafter according to the presence and severity of NeuP. The DN4 questionnaire demonstrated excellent sensitivity (88%) and specificity (93%) in screening for NeuP. There was a positive correlation between greater neuropathy severity (r = 0.39, P < 0.01), higher HbA1c (r = 0.21, P < 0.01), and the presence (and severity) of NeuP. Diabetic peripheral neuropathy sensory phenotype is characterised by hyposensitivity to applied stimuli that was more marked in the moderate/severe NeuP group than in the mild NeuP or no NeuP groups. Brush-evoked allodynia was present in only those with NeuP (15%); the paradoxical heat sensation did not discriminate between those with (40%) and without (41.3%) NeuP. The “irritable nociceptor” subgroup could only be applied to a minority of patients (6.3%) with NeuP. This study provides a firm basis to rationalise further phenotyping of painful DPN, for instance, stratification of patients with DPN for analgesic drug trials.
spellingShingle Themistocleous, A
Ramirez, J
Shillo, P
Lees, J
Selvarajah, D
Orengo, C
Tesfaye, S
Rice, A
Bennett, D
The Pain in Neuropathy Study (PiNS)
title The Pain in Neuropathy Study (PiNS)
title_full The Pain in Neuropathy Study (PiNS)
title_fullStr The Pain in Neuropathy Study (PiNS)
title_full_unstemmed The Pain in Neuropathy Study (PiNS)
title_short The Pain in Neuropathy Study (PiNS)
title_sort pain in neuropathy study pins
work_keys_str_mv AT themistocleousa thepaininneuropathystudypins
AT ramirezj thepaininneuropathystudypins
AT shillop thepaininneuropathystudypins
AT leesj thepaininneuropathystudypins
AT selvarajahd thepaininneuropathystudypins
AT orengoc thepaininneuropathystudypins
AT tesfayes thepaininneuropathystudypins
AT ricea thepaininneuropathystudypins
AT bennettd thepaininneuropathystudypins
AT themistocleousa paininneuropathystudypins
AT ramirezj paininneuropathystudypins
AT shillop paininneuropathystudypins
AT leesj paininneuropathystudypins
AT selvarajahd paininneuropathystudypins
AT orengoc paininneuropathystudypins
AT tesfayes paininneuropathystudypins
AT ricea paininneuropathystudypins
AT bennettd paininneuropathystudypins